NDC 59762-2010-01 - amlodipine besylate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 59762-2010
- Requested NDC
- 59762-2010-01
- Package NDCs from labels
- 59762-2010-9, 59762-2010-3, 59762-2010-1, 59762-2010-01
- Manufacturer
- Mylan Pharmaceuticals Inc.
- Effective date
- 2024-11-28
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| amlodipine besylate - Mylan Pharmaceuticals Inc. | Mylan Pharmaceuticals Inc. | 2024-11-28 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 59762-2010-1 | amlodipine besylate | 1000 in 1 BOTTLE | TABLET | 1000 | 32 | |
| 59762-2010-3 | amlodipine besylate | 300 in 1 BOTTLE | TABLET | 300 | 32 | |
| 59762-2010-9 | amlodipine besylate | 90 in 1 BOTTLE | TABLET | 90 | 32 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 59762-2010 | AMLODIPINE BESYLATE TABLET [MYLAN PHARMACEUTICALS INC.] | 31 | Current NDC, Legacy NDC, 3 package rows | 20250502_180ee374-24f2-4b9c-9d54-8815f2b1dc9b.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 59762-2010-1 | EA - Each | 59762-2010 | 02138dd6-d473-4892-b0ae-8c78a8d4437f | 1 | 2019-07-02 |
| 59762-2010-3 | EA - Each | 59762-2010 | 51b3ff67-f1e1-4b68-8f57-97363b780902 | 1 | 2019-07-02 |
| 59762-2010-9 | EA - Each | 59762-2010 | baddac96-f6f2-46c8-a173-93e23006f4f3 | 1 | 2019-07-02 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| AMLODIPINE BESYLATE | ACTIVE INGREDIENT | 864V2Q084H | AMLODIPINE BESYLATE TABLET [GREENSTONE LLC] | 19 | |
| AMLODIPINE | ACTIVE MOIETY | 1J444QC288 | AMLODIPINE BESYLATE TABLET [GREENSTONE LLC] | 19 | |
| CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS | INACTIVE INGREDIENT | L11K75P92J | AMLODIPINE BESYLATE TABLET [GREENSTONE LLC] | 19 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | AMLODIPINE BESYLATE TABLET [GREENSTONE LLC] | 19 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | AMLODIPINE BESYLATE TABLET [GREENSTONE LLC] | 19 | |
| SODIUM STARCH GLYCOLATE TYPE A POTATO | INACTIVE INGREDIENT | 5856J3G2A2 | AMLODIPINE BESYLATE TABLET [GREENSTONE LLC] | 19 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Amlodipine and Valsartan | AMLODIPINE AND VALSARTAN | Alembic Pharmaceuticals Inc. | 6894085d-6076-4e2e-8105-a9bbb0bd93ef | 2024-06-21 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine Besylate | AMLODIPINE BESYLATE | Ascend Laboratories, LLC | 3f4703c0-0b9e-41a0-8b70-da26683d9ed2 | 2024-06-21 | Warnings, Adverse reactions | 197361 308136 308135 864V2Q084H |
| Amlodipine Besylate | AMLODIPINE BESYLATE | NuCare Pharmaceuticals,Inc. | 9c448d87-294e-3325-e053-2a95a90a2299 | 2024-06-20 | Warnings, Adverse reactions | 197361 864V2Q084H |
| Amlodipine and Benazepril Hydrochloride | AMLODIPINE AND BENAZEPRIL HYDROCHLORIDE | Aurobindo Pharma Limited | 99ed4927-9a34-4e8d-8eea-60b63c867d46 | 2024-06-20 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine Besylate | AMLODIPINE BESYLATE | Direct_Rx | 094498f2-11d9-2a05-e063-6294a90ab2e1 | 2024-06-13 | Warnings, Adverse reactions | 197361 864V2Q084H |
| Amlodipine Besylate | AMLODIPINE BESYLATE | A-S Medication Solutions | 5a67bbdc-ac1f-4778-bbdc-929df140b7f5 | 2024-06-10 | Warnings, Adverse reactions | 308135 864V2Q084H |
| Amlodipine Besylate | AMLODIPINE BESYLATE | NuCare Pharmaceuticals,Inc. | 638d86ab-986b-59ed-e053-2a91aa0a98ee | 2024-06-06 | Warnings, Adverse reactions | 197361 864V2Q084H |
| Amlodipine and valsartan | AMLODIPINE AND VALSARTAN | Aurobindo Pharma Limited | 7fa25f10-29e0-4162-81a8-9d2e03054ded | 2024-05-17 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine, Valsartan and Hydrochlorothiazide | AMLODIPINE, VALSARTAN AND HYDROCHLOROTHIAZIDE | Aurobindo Pharma Limited | 6fba5243-ee00-4825-a04a-321cb6b49c56 | 2024-05-17 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine Besylate | AMLODIPINE BESYLATE | NuCare Pharmaceuticals,Inc. | ca8c6ca7-79c6-5299-e053-2a95a90a790d | 2024-05-15 | Warnings, Adverse reactions | 308135 864V2Q084H |
| Amlodipine and Olmesartan Medoxomil | AMLODIPINE AND OLMESARTAN MEDOXOMIL | Aurobindo Pharma Limited | b13a8b46-104e-4b75-8f4a-928d2204eff5 | 2024-04-15 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide | OLMESARTAN MEDOXOMIL / AMLODIPINE BESYLATE / HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | a6ebafdc-4301-4d6c-b578-b3212648b13a | 2024-04-08 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine besylate | AMLODIPINE BESYLATE | Bryant Ranch Prepack | c3742b31-11f6-4c11-98e3-75916a1982d4 | 2024-04-04 | Warnings, Adverse reactions | 308136 864V2Q084H |
| Amlodipine besylate | AMLODIPINE BESYLATE | Bryant Ranch Prepack | f968393f-47d2-4c16-b34f-93a9d61adb9e | 2024-04-04 | Warnings, Adverse reactions | 308135 864V2Q084H |
| AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | Aphena Pharma Solutions - Tennessee, LLC | d17ef907-7719-4246-8ade-b67afdfaf787 | 2024-03-26 | Warnings, Adverse reactions | 308135 864V2Q084H |
| AMLODIPINE BESYLATE 10 mg | AMLODIPINE BESYLATE | NuCare Pharmaceuticals,Inc. | ffe96aa1-db66-33e4-e053-6394a90a7e4e | 2024-03-26 | Warnings, Adverse reactions | 308135 864V2Q084H |
| Amlodipine and Olmesartan Medoxomil | AMLODIPINE AND OLMESARTAN MEDOXOMIL | Amneal Pharmaceuticals NY LLC | 02f9b562-6f7f-4783-bb0d-67c318073e1c | 2024-03-26 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| AMLODIPINE BESYLATE 2.5 mg | AMLODIPINE BESYLATE | Aphena Pharma Solutions - Tennessee, LLC | 132c078d-7d31-a6f2-e063-6294a90af095 | 2024-03-08 | Warnings, Adverse reactions | 308136 864V2Q084H |
| Amlodipine Besylate | AMLODIPINE BESYLATE | Bryant Ranch Prepack | 52daa759-3327-461a-8cfc-3c6253df91ec | 2024-03-05 | Warnings, Adverse reactions | 197361 864V2Q084H |
| Amlodipine Besylate | AMLODIPINE BESYLATE | Teva Pharmaceuticals, Inc. | 47edc328-2444-4ca1-a5c1-7c83141e105c | 2024-03-01 | Warnings, Adverse reactions | 197361 308136 308135 864V2Q084H |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.